Page last updated: 2024-08-24

halofuginone and Hepatitis B

halofuginone has been researched along with Hepatitis B in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, N; Kang, Y; Mao, C; Shang, J; Zhan, W	1

Other Studies

1 other study(ies) available for halofuginone and Hepatitis B

Article	Year
Halofuginone ameliorates inflammation in severe acute hepatitis B virus (HBV)-infected SD rats through AMPK activation. Drug design, development and therapy, 2017, Volume: 11 Topics: Acute Disease; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Inflammation; Piperidines; Quinazolinones; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Transcription Factor RelA	2017

Article

Year

Halofuginone ameliorates inflammation in severe acute hepatitis B virus (HBV)-infected SD rats through AMPK activation.

Drug design, development and therapy, 2017, Volume: 11

Topics: Acute Disease; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Inflammation; Piperidines; Quinazolinones; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Transcription Factor RelA

2017